How we helped a Japanese innovator in cancer Dx estimate its market size and understand the future market dynamics
The challenge: Estimating the market size of innovative cancer Dx in Japan A…
How our competitive simulation workshop helped a large pharma in precision oncology, develop its branding strategy for upcoming EU launches.
The Challenge: Formulating a brand strategy for new treatment launches in…
From Scarcity to Sufficiency: Understanding and Resolving the Cancer Drug Shortage in the United States
The US has been struggling with a severe cancer drug shortage for several…
Coupling state-of-the-art technologies: CRISPR in the service of CAR-T immunotherapy
Cancer is the second leading cause of death worldwide. Many research and…
How will AI transform the way we treat cancer?
Cancer is one of the top causes of death worldwide. According to the American…
Oncolytic viruses: From promise to reality
The countless cytotoxic effects of traditional chemotherapy have created the…
